Hemab Therapeutics

About Hemab Therapeutics

Hemab is a biotechnology company focused on developing targeted therapies to prevent bleeding in patients with underserved bleeding disorders. Their mission is to offer new hope and innovative treatments for conditions overlooked by modern medicine, aiming to shift the standard of care from management to prevention.

Products & Services

HMB-002:A therapy in development for Von Willebrand Disease, with ongoing clinical trials including the VELORA Discover Screening Study and VELORA Pioneer Phase 1/2 Study.

Sutacimig (HMB-001):A prophylactic treatment for Glanzmann Thrombasthenia, with interim Phase 2 data presented and a Phase 2 study fully enrolled.

Specialties

Bleeding Disorders Therapeutic Development for Glanzmann Thrombasthenia Therapeutic Development for Von Willebrand Disease Therapeutic Development for FVII Deficiency Clinical Trials for Bleeding Disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 346700000 MR: - FA: 346.7 million FAN: 346700000	D: 2026-05-04 FD: 2026-05-04	4 investors
2	RT: IPO T: - FT: IPO	A: 301500000 MR: - FA: approximately $301.5 million FAN: 301500000	D: 2026-04-30 FD: 2026-04-30	4 investors
3	RT: Series C T: - FT: Series C	A: 157000000 MR: - FA: $157 million FAN: 157000000	D: 2025-10-27 FD: 2025-10-27	13 investors
4	RT: Series B T: - FT: Series B	A: 135000000 MR: - FA: $135 million FAN: 135000000	D: 2023-02-21 FD: 2023-02-21	9 investors

IPO Latest

2026-05-04

$346.7M

4 investors (Pro only)

IPO 2026-04-30

$301.5M

Series C 2025-10-27

$157.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joe Anderson

Partner, Sofinnova Partners

S

Shirley He

Associate Director, Biostatistics

P

Peter Nørkjær Laursen

Medical Director

A

Anant Murthy

Chief Operating Officer

A

Angela Volkert

Vice President, Clinical Research

M

Matthew Bandel

Senior Clinical Trial Associate

View 64 more team members with Pro

Unlock Full Team Directory

Recent News